Decreased flow-mediated dilatation in patients with rheumatoid arthritis: A meta-analysis

Postgraduate Medical Journal

Volumn 93, Issue 1099, 2017, Pages 260-265

  Xu, Shu Zhen ^a,b   Wang, Peng ^a,b   Guan, Shi Yang ^a,b   Li, Hong Miao ^a,b   Leng, Rui Xue ^a,b   Pan, Hai Feng ^a,b   Ye, Dong Qing ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui Provincial Laboratory of Population Health Major Disease Screening and Diagnosis   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; DISEASE DURATION; ECHOGRAPHY; FLOW-MEDIATED DILATION TEST; HUMAN; META ANALYSIS (TOPIC); PUBLISHING; RHEUMATOID ARTHRITIS; BLOOD FLOW VELOCITY; META ANALYSIS; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; VASCULAR DISEASE; VASODILATATION;

ARTHRITIS, RHEUMATOID; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; HUMANS; RISK ASSESSMENT; RISK FACTORS; VASCULAR DISEASES; VASODILATION;

EID: 84994876957     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2016-134068     Document Type: Article

References (47)

1. Lee YH, Bae SC, Choi SJ, et al. Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis. Mol Biol Rep 2012;39:10627–35.
2. Wang HQ, Ye YF, Rao JM, et al. An epidemiology survey on rheumatic arthritis among the residents aged 15. years and above in Guangzhou City. Chin J Dis Control Prev 2015;19:999–1002.
3. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481–94.
4. Rho YH, Chung CP, Oeser A, et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2009;61:1580–5.
5. McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006;54:2541–9.
6. O’Neill SG, Giles I, Lambrianides A, et al. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2010;62:845–54.
7. Piper MK, Raza K, Nuttall SL, et al. Impaired endothelial function in systemic lupus erythematosus. Lupus 2007;16:84–8.
8. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–7.
9. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722–32.
10. Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862–73.
11. Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337–47.
12. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685–95.
13. Tyrrell PN, Beyene J, Feldman BM, et al. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2010;30:1014–26.
14. Yeboah J, Crouse JR, Hsu FC, et al. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study. Circulation 2007;115:2390–7.
15. Wang DG, Tang XW, Fan Y, et al. Decreased flow-mediated dilatation in patients with systemic lupus erythematosus: a meta-analysis. Inflammation 2014;37:2067–75.
16. Prati C, Demougeot C, Guillot X, et al. Endothelial dysfunction in joint disease. Joint Bone Spine 2014;81:386–91.
17. Ghiadoni L, Tani C, Bruno RM, et al. Prognostic value of flow-mediated dilation in patients with systemic lupus erythematosus: a pilot prospective cohort study. Atherosclerosis 2014;236:381–4.
18. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 2008;38:67–70.
19. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
21. Robert K, Pagès C, Ledru A, et al. Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus. Neuroscience 2005;133:925–35.
22. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58.
23. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–60.
24. Whitlock RP, Chan S, Devereaux PJ, et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J 2008;29:2592–600.
25. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001;54:1046–55.
26. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34.
27. Amin MA, Salama AA, Elaggan AM, et al. Brachial artery flow mediated dilatation and carotid intima media thickness measured by high resolution B-mode ultrasound in patients with rheumatoid arthritis. Egyptian J Radiol Nucl Med 2015;46:89–96.
28. Irace C, Mancuso G, Fiaschi E, et al. Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol. Atherosclerosis 2004;177:113–18.
29. Protogerou AD, Zampeli E, Fragiadaki K, et al. A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6. receptor inhibition in rheumatoid arthritis. Atherosclerosis 2011;219:734–6.
30. Cypiene A, Dadoniene J, Rugiene R, et al. The influence of mean blood pressure on arterial stiffening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus. Medicina 2010;46:522–30.
31. Sarli B, Baktir AO, Cebicci M, et al. Predictors of endothelial dysfunction in patients with rheumatoid arthritis. Angiology 2014;65:778–82.
32. Temiz A, Gokmen F, Gazi E, et al. Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: Associations in rheumatoid arthritis patients. Herz 2015;40(Suppl 3):217–24.
33. Bosello S, Santoliquido A, Zoli A, et al. TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. Clin Rheumatol 2008;27:833–9.
34. Veselinovic MV, Zivkovic VI, Toncev S, et al. Carotid artery intima-media thickness and brachial artery flow-mediated vasodilatation in patients with rheumatoid arthritis. Vasa 2012;41:343–51.
35. Chatterjee Adhikari M, Guin A, Chakraborty S, et al. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 2012;41:669–75.
36. Kassem E, Ghonimy R, Adel M, et al. Non traditional risk factors of carotid atherosclerosis in rheumatoid arthritis. Egyptian Rheumatologist 2011;33:113–19.
37. Scarno A, Perrotta FM, Cardini F, et al. Beyond the joint: subclinical atherosclerosis in rheumatoid arthritis. World J Orthop 2014;5:328–35.
38. Sandoo A, Hodson J, Douglas KM, et al. The association between functional and morphological assessments of endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2013;15:R107.
39. Arrebola-Moreno AL, Laclaustra M, Kaski JC. Noninvasive assessment of endothelial function in clinical practice. Rev Esp Cardiol (Engl Ed) 2012;65:80–90.
40. Fan CY, Zhang ZY, Mei YF, et al. Impaired brachial artery flow-mediated dilation and increased carotid intima-media thickness in rheumatoid arthritis patients. Chin Med J 2012;125:832–7.
41. Abdelmaboud NM, Elsaid HH. Endothelial dysfunction and subclinical atherosclerosis as evidenced by the measurement of flow mediated dilatation of brachial artery and carotid intima media thickness in patients with rheumatoid arthritis. Egyptian J Radiol Nuclear Med 2013;44:237–43.
42. Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 2004;63:952–5.
43. Haque S, Mirjafari H, Bruce IN. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Curr Opin Lipidol 2008;19:338–43.
44. John H, Kitas G, Toms T, et al. Cardiovascular co-morbidity in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2009;23:71–82.
45. Yoshizumi M, Perrella MA, Burnett JC Jr, et al. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993;73:205–9.
46. Kessler P, Popp R, Busse R, et al. Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism. Circulation 1999;99:1878–84.
47. Hingorani AD, Cross J, Kharbanda RK, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000;102:994–9.